Scrying Biotech
Long only, biotech, micro-cap, small-cap

Synergy Pharmaceuticals: There's Strength In Safety

The strong equities market of 2013 has benefited from the participation of individual investors such as myself who have arrived late in life with modest resources and great enthusiasm. We rarely buy large positions in a single trade but rather accumulate shares over time. Once enlarged, we can ill-afford to hold our equity through problematic binary events incurring massive portfolio losses.

This new investor profile of finite resources and abundant desire demands a strategy that emphasizes safety and proper timing. Reading the blueprint means identifying companies with strong financial positions, which essentially means no debt and a substantial amount of working capital preferably from recent financing activity.

Strength of Safety: Synergy's Solid Financial Position

Synergy Pharmaceuticals (SGYP) is...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details